These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2611942)

  • 1. Binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction.
    Matsumoto K; Miyazaki H; Fujii T; Amejima H; Furukawa H; Hashimoto M
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2807-10. PubMed ID: 2611942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of sulfonamides to erythrocytes and their components.
    Matsumoto K; Miyazaki H; Fujii T; Hashimoto M
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1913-5. PubMed ID: 2805171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro.
    Lin JH; Lin TH; Cheng H
    Pharm Res; 1992 Mar; 9(3):339-44. PubMed ID: 1614967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1981 Dec; 30(24):3347-54. PubMed ID: 7326045
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood.
    Bongard HJ; Pluim D; Waardenburg RC; Ravic M; Beijnen JH; Schellens JH
    Anticancer Drugs; 2003 Jul; 14(6):405-10. PubMed ID: 12853880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.
    Berneis K; Boguth W
    Chemotherapy; 1976; 22(6):390-409. PubMed ID: 954483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saturable binding of indisulam to plasma proteins and distribution to human erythrocytes.
    Zandvliet AS; Copalu W; Schellens JH; Beijnen JH; Huitema AD
    Drug Metab Dispos; 2006 Jun; 34(6):1041-6. PubMed ID: 16565173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of diazepam with human, rat and mouse plasma proteins and erythrocytes.
    Láznícek M; Lamka J; Kvĕtina J
    Biochem Pharmacol; 1982 Apr; 31(7):1455-8. PubMed ID: 7092935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
    Lin JH; Ulm EH; Los LE
    Drug Metab Dispos; 1991; 19(1):233-8. PubMed ID: 1673405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro.
    Hasegawa T; Hara K; Hata S
    Drug Metab Dispos; 1994; 22(3):377-82. PubMed ID: 8070313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of zonisamide; saturable distribution into human and rat erythrocytes and into rat brain.
    Nishiguchi K; Ohnishi N; Iwakawa S; Yagi J; Nakayama S; Takada S; Nakamura H; Yokoyama T; Okumura K
    J Pharmacobiodyn; 1992 Aug; 15(8):409-15. PubMed ID: 1479541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of acetazolamide by human erythrocytes in vitro.
    Wallace SM; Reigelman S
    J Pharm Sci; 1977 May; 66(5):729-31. PubMed ID: 874760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier transport of CI-912: single-passage equilibration of erythrocyte-borne drug.
    Cornford EM; Landon KP
    Ther Drug Monit; 1985; 7(3):247-54. PubMed ID: 4049458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.
    Lemaire M; Tillement JP
    J Pharm Pharmacol; 1982 Nov; 34(11):715-8. PubMed ID: 6129301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear dorzolamide pharmacokinetics in rats: concentration-dependent erythrocyte distribution and drug-metabolite displacement interaction.
    Wong BK; Bruhin PJ; Barrish A; Lin JH
    Drug Metab Dispos; 1996 Jun; 24(6):659-63. PubMed ID: 8781782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of diuretics and hypoglycemic sulfonylureas in rabbit erythrocytes.
    Yoshitomi H; Kiko S; Ikeda K; Goto S
    J Pharmacobiodyn; 1983 Mar; 6(3):177-83. PubMed ID: 6875798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of bismuth in the rat. I. Red blood cell and plasma protein binding.
    Rao N; Feldman S
    Pharm Res; 1990 Feb; 7(2):188-91. PubMed ID: 2308899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug displacement from protein binding: source of the sulphadoxine liberated by phenylbutazone.
    Wardell WM
    Br J Pharmacol; 1971 Oct; 43(2):325-34. PubMed ID: 5158201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding and erythrocyte partitioning of nicardipine in vitro.
    Urien S; Albengres E; Comte A; Kiechel JR; Tillement JP
    J Cardiovasc Pharmacol; 1985; 7(5):891-8. PubMed ID: 2413297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of sulfonylurea derivatives to bovine serum albumin: part II. The relationship of binding to albumin, chemical structure, and hypoglycemic activity of sulfonamide derivatives of 2-pyrazoline-1-carboxamide.
    Wójcikowski C; Brzozowski Z; Chorosiński A
    Pol J Pharmacol Pharm; 1977; 29(5):477-83. PubMed ID: 593965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.